CDH1 and adenocarcinoma: We also performed an in vitro investigation on the effect of lncCDH5-3:3 silencing and overexpression on the cell cycle, proliferation, apoptosis, and expression of CDH1 and EPCAM in the adenocarcinoma and squamous cell carcinoma cell lines.